Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Atsushi Hayata"'
Autor:
Eriko Murakami, Hiroaki Akamatsu, Shunsuke Teraoka, Toshiaki Takakura, Eri Takase, Masanori Tanaka, Takahiro Kaki, Yuhei Harutani, Katsuyuki Furuta, Takeya Sugimoto, Ryota Shibaki, Daichi Fujimoto, Atsushi Hayata, Yuichi Ozawa, Masanori Nakanishi, Yasuhiro Koh, Toshio Shimokawa, Nobuyuki Yamamoto
Publikováno v:
Cancer Medicine, Vol 13, Iss 4, Pp n/a-n/a (2024)
Abstract Background Mannitol is exclusively recommended in the National Comprehensive Cancer Network guidelines for diuresis in cisplatin (CDDP)‐based chemotherapy. The utility of furosemide, a widely used and convenient diuretic, thus requires cla
Externí odkaz:
https://doaj.org/article/936934c8acbe4ec093a80de605ccb236
Autor:
Ryota Shibaki, Yuichi Ozawa, Susumu Noguchi, Yusuke Murakami, Eri Takase, Yuichiro Azuma, Masaru Maebeya, Takeya Sugimoto, Atsushi Hayata, Takahiro Hayakawa, Shinya Tamaki, Masanori Nakanishi, Shunsuke Teraoka, Hiroaki Akamatsu
Publikováno v:
Cancer Medicine, Vol 11, Iss 20, Pp 3743-3750 (2022)
Abstract Background First‐generation epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) sometimes causes lung injury, thereby affecting survival. Although pre‐existing interstitial lung abnormal shadow (pre‐ILS) increases
Externí odkaz:
https://doaj.org/article/8ce8e7d2fc4341d99d6345df94b68b97
Autor:
Yuya Yoshioka, Kouji Kobiyama, Tomoya Hayashi, Motoyasu Onishi, Yosuke Yanagida, Takayuki Nakagawa, Masayuki Hashimoto, Anri Nishinaka, Jun Hirose, Yoshiji Asaoka, Minako Tajiri, Atsushi Hayata, Satoru Ishida, Shinya Omoto, Morio Nagira, Ken J. Ishii
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundAdjuvants are chemical or biological materials that enhance the efficacy of vaccines. A-910823 is a squalene-based emulsion adjuvant used for S-268019-b, a novel vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) t
Externí odkaz:
https://doaj.org/article/660750c5f8eb4c1bbea1804e0ac9e01b
Autor:
Mio Ikeda, Yasuhiro Koh, Shunsuke Teraoka, Koichi Sato, Kuninobu Kanai, Atsushi Hayata, Nahomi Tokudome, Hiroaki Akamatsu, Yuichi Ozawa, Keiichiro Akamatsu, Katsuya Endo, Masayuki Higuchi, Masanori Nakanishi, Hiroki Ueda, Nobuyuki Yamamoto
Publikováno v:
Cancer Medicine, Vol 9, Iss 6, Pp 2122-2133 (2020)
Abstract Noninvasive diagnostics using circulating tumor cells (CTCs) are expected to be useful for decision making in precision cancer therapy. AXL, a receptor tyrosine kinase is associated with tumor progression, epithelial‐to‐mesenchymal trans
Externí odkaz:
https://doaj.org/article/93df0d4a0bea451c9197d68d6d5d0747
Autor:
Hiroaki Akamatsu, MD, PhD, Shunsuke Teraoka, MD, Hidetoshi Hayashi, MD, PhD, Daichi Fujimoto, MD, Atsushi Hayata, MD, PhD, Koji Haratani, MD, PhD, Yuichi Ozawa, MD, PhD, Takeshi Yoshida, MD, PhD, Tsutomu Iwasa, MD, PhD, Toshio Shimokawa, MD, Keisuke Tomii, MD, PhD, Kazuhiko Nakagawa, MD, PhD, Nobuyuki Yamamoto, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 7, Pp 100184- (2021)
Introduction: In patients with relapsed SCLC, amrubicin (AMR) is the current standard treatment in Japan. Nevertheless, its efficacy is not satisfactory and prognosis is poor. Preclinical study suggested that anthracycline agent might induce immunoge
Externí odkaz:
https://doaj.org/article/772e441e14ed494d9dc68a90b6f84b8f
Autor:
Katsuyuki Furuta, Hiroaki Akamatsu, Ryuichi Sada, Kyohei Miyamoto, Shunsuke Teraoka, Atsushi Hayata, Yuichi Ozawa, Masanori Nakanishi, Yasuhiro Koh, Nobuyuki Yamamoto
Publikováno v:
Acute Medicine & Surgery, Vol 8, Iss 1, Pp n/a-n/a (2021)
Aim The emergency department requires simple and useful clinical indicators to identify bacteremia. This retrospective study explored the Systemic Inflammatory Response Syndrome (SIRS) and quick Sequential Organ Failure Assessment (qSOFA) scores for
Externí odkaz:
https://doaj.org/article/1b0bd88407f2442dad2339088b14c235
Autor:
Satomi Yagi, Yasuhiro Koh, Hiroaki Akamatsu, Kuninobu Kanai, Atsushi Hayata, Nahomi Tokudome, Keiichiro Akamatsu, Katsuya Endo, Seita Nakamura, Masayuki Higuchi, Hisashige Kanbara, Masanori Nakanishi, Hiroki Ueda, Nobuyuki Yamamoto
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179744 (2017)
Circulating tumor cells (CTCs), defined as tumor cells circulating in the peripheral blood of patients with solid tumors, are relatively rare. Diagnosis using CTCs is expected to help in the decision-making for precision cancer medicine. We have deve
Externí odkaz:
https://doaj.org/article/9cf28ee5e7b1459cbef8ed0437b545d4
Autor:
Atsushi Hayata, Kazuto Matsunaga, Tsunahiko Hirano, Keiichiro Akamatsu, Tomohiro Ichikawa, Yoshiaki Minakata, Masakazu Ichinose
Publikováno v:
Allergology International, Vol 62, Iss 3, Pp 343-349 (2013)
Background: Recently, correlations of peak expiratory flow (PEF) variation have been shown to facilitate the prediction of later asthma symptoms and exacerbations. However, it has not been fully examined whether or not any patient characteristics are
Externí odkaz:
https://doaj.org/article/31280434c2684d84968e87c801f187bf
Autor:
Eri Takase, Hiroaki Akamatsu, Shunsuke Teraoka, Keita Nakaguchi, Masanori Tanaka, Takahiro Kaki, Katsuyuki Furuta, Koichi Sato, Eriko Murakami, Takeya Sugimoto, Ryota Shibaki, Daichi Fujimoto, Atsushi Hayata, Nahomi Tokudome, Yuichi Ozawa, Yasuhiro Koh, Masanori Nakanishi, Kuninobu Kanai, Toshio Shimokawa, Nobuyuki Yamamoto
Background: The efficacy and tolerability of high-flow nasal cannula (HFNC) for relieving dyspnea in advanced cancer patients with limited prognosis requires elucidation. Methods: Patients with advanced cancer who had dyspnea at rest (numeric rating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::053072e04eee67e8700506ed3cf47b14
https://doi.org/10.21203/rs.3.rs-2639256/v1
https://doi.org/10.21203/rs.3.rs-2639256/v1
Autor:
Takashi Akamizu, Chiaki Kurimoto, Yasushi Furukawa, Masatoshi Jinnin, Hidefumi Inaba, Hiroshi Iwakura, Shuhei Morita, Ken Takeshima, Yuki Yamamoto, Hiroaki Akamatsu, Hiroyuki Ariyasu, Hiroki Yamaue, Yoko Ueda, Shinsuke Uraki, Atsushi Hayata, Masahiro Katsuda, Shimpei Yamashita, Isao Hara
Publikováno v:
Cancer Science
Immune‐related adverse events (irAEs) are often seen during immune‐checkpoint inhibitor (ICI) treatment of various malignancies. Endocrine irAEs including thyroid dysfunctions are the most common irAEs, but their biomarkers remain unclear. In ord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c7bb816af4e3455bc200c5713f08af4
https://doi.org/10.1111/cas.14363
https://doi.org/10.1111/cas.14363